相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dialogue among Lymphocytes and Microglia in Glioblastoma Microenvironment
Alessandro Mormino et al.
CANCERS (2022)
Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
Jang Mi Han et al.
CANCERS (2022)
Physics of Brain Cancer: Multiscale Alterations of Glioblastoma Cells under Extracellular Matrix Stiffening
Mohammad Khoonkari et al.
PHARMACEUTICS (2022)
Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment
Yue Zhou et al.
THERANOSTICS (2022)
LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion
Wei-Jiang Zhao et al.
JOURNAL OF CANCER (2022)
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
Yaomei Tian et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Adeno-associated virus (AAV)-based gene therapy for glioblastoma
Xin Xu et al.
CANCER CELL INTERNATIONAL (2021)
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Juri Kiyokawa et al.
CLINICAL CANCER RESEARCH (2021)
Myeloid Cells in Glioblastoma Microenvironment
Alessandra De Leo et al.
CELLS (2021)
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Sharmila Nair et al.
JCI INSIGHT (2021)
Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma
Jianhan Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesicles
Yoshihiko Kakiuchi et al.
MOLECULAR THERAPY (2021)
Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas
Dagoberto Estevez-Ordonez et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2021)
Current Approaches for Glioma Gene Therapy and Virotherapy
Kaushik Banerjee et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Putting Proteomics Into Immunotherapy for Glioblastoma
Liangyu Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
Rui Ma et al.
CANCER RESEARCH (2021)
HSV-1 G207 is active in paediatric glioma
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
Natalia Vasileva et al.
LIFE-BASEL (2021)
Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells
Mariangela Garofalo et al.
PHARMACEUTICS (2021)
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma
Jorge A. Benitez et al.
NEURO-ONCOLOGY (2021)
Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma
Fan Xing et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Zhe Zhu et al.
CELL STEM CELL (2020)
Development of oncolytic virotherapy: from genetic modification to combination therapy
Lan Qiaoshuai et al.
FRONTIERS OF MEDICINE (2020)
Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca2+-dependent CaMKII/JNK cascade
Xue-Chang Han et al.
LIFE SCIENCES (2020)
The Interplay between Adeno-Associated Virus and Its Helper Viruses
Anita F. Meier et al.
VIRUSES-BASEL (2020)
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
Jinlong Yin et al.
NATURE COMMUNICATIONS (2020)
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Tobias Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Francesca Petralia et al.
CELL (2020)
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
Ming Li et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
Mark W. Kieran et al.
NEURO-ONCOLOGY (2019)
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
Francesco Alessandrini et al.
ONCOGENE (2019)
Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways
Yusuke Tomita et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo
Ji Young Yoo et al.
NEURO-ONCOLOGY (2019)
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
Matteo Ligorio et al.
CELL (2019)
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye et al.
NATURE BIOTECHNOLOGY (2019)
Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?
Kar Yan Su et al.
FRONTIERS IN MICROBIOLOGY (2019)
MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis
Chong Hyun Suh et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)
An oncolytic herpesvirus expressing E-cacherin improves survival in mouse models of glioblastoma
Bo Xu et al.
NATURE BIOTECHNOLOGY (2019)
Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2019)
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival
Paola Sette et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
David M. Peereboom et al.
JCI INSIGHT (2019)
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro et al.
NEURO-ONCOLOGY (2018)
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
Dipongkor Saha et al.
CLINICAL CANCER RESEARCH (2018)
Armed oncolytic viruses: A kick-start for anti-tumor immunity
J. F. de Graaf et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells
Cole Peters et al.
JOURNAL OF VIROLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Wouter B. L. van den Bossche et al.
NEURO-ONCOLOGY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Ovrexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
Xiaoyong Fan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
Qi Chen et al.
MBIO (2018)
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
Yang Bai et al.
SCIENTIFIC REPORTS (2018)
Human endogenous retrovirus-K (HML-2): a comprehensive review
Marta Garcia-Montojo et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2018)
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban et al.
JCI INSIGHT (2018)
Cancer stem cell-targeted therapeutics and delivery strategies
Gulzar Ahmad et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment
Jayson Hardcastle et al.
NEURO-ONCOLOGY (2017)
Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
Nusrat Jahan et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Zika virus has oncolytic activity against glioblastoma stem cells
Zhe Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The role of bevacizumab in the treatment of glioblastoma
Roberto Jose Diaz et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan D. Chow et al.
NATURE NEUROSCIENCE (2017)
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
Leah A. Mitchell et al.
NEURO-ONCOLOGY (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
Assia L. Angelova et al.
VIRUSES-BASEL (2017)
A practical guide to the handling and administration of talimogene laherparepvec in Europe
Kevin J. Harrington et al.
ONCOTARGETS AND THERAPY (2017)
Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption
Michelle P. Papa et al.
FRONTIERS IN MICROBIOLOGY (2017)
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity
Anne Kleijn et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang et al.
CANCER RESEARCH (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
Julia V. Cockle et al.
NEURO-ONCOLOGY (2016)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
Siri Tähtinen et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos et al.
STEM CELLS (2016)
The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein
Liang-Tzung Lin et al.
VIRUSES-BASEL (2016)
Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
Rafael Josupeit et al.
VIRUSES-BASEL (2016)
Measles to the Rescue: A Review of Oncolytic Measles Virus
Sarah Aref et al.
VIRUSES-BASEL (2016)
Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression
Jeremy T. Miyauchi et al.
ONCOTARGET (2016)
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa M. Patel et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2016)
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
Michael Zhang et al.
PLOS ONE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus
Chang Yoon Moon et al.
BIOMATERIALS (2015)
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma
Hiroshi Nakashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV
Lucia Mazzacurati et al.
MOLECULAR THERAPY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Prospects of immune checkpoint modulators in the treatment of glioblastoma
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2015)
Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
Angelica Loskog
VIRUSES-BASEL (2015)
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor
Siri Tahtinen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model
Stephanie Du Four et al.
ONCOIMMUNOLOGY (2015)
Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors
Nobuhiro Nishio et al.
ONCOIMMUNOLOGY (2015)
Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy
Jian Qiao et al.
ONCOIMMUNOLOGY (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
S. Han et al.
BRITISH JOURNAL OF CANCER (2014)
Immunotherapy for Brain Cancer: Recent Progress and Future Promise
Christopher M. Jackson et al.
CLINICAL CANCER RESEARCH (2014)
Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
Matthias Duebgen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma
Ian E. Haines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
Hong Jiang et al.
PLOS ONE (2014)
Oncolytic Viruses and Their Application to Cancer Immunotherapy
E. Antonio Chiocca et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Activated Ras signaling pathways and reovirus oncolysis an update on the mechanism of preferential reovirus replication in cancer cells
Jun Gong et al.
FRONTIERS IN ONCOLOGY (2014)
Zika Virus, French Polynesia, South Pacific, 2013 Response
Van-Mai Cao-Lormeau
EMERGING INFECTIOUS DISEASES (2014)
Going viral with cancer immunotherapy
Brian D. Lichty et al.
NATURE REVIEWS CANCER (2014)
Oncolytic viral therapy for pancreatic cancer: current research and future directions
Justin W. Ady et al.
ONCOLYTIC VIROTHERAPY (2014)
Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
Anna Carolina Carvalho da Fonseca et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation
B. Thaci et al.
GENE THERAPY (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
Tooba A. Cheema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Adeno-Associated Virus Enhances Wild-Type and Oncolytic Adenovirus Spread
Eduardo Laborda et al.
HUMAN GENE THERAPY METHODS (2013)
Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
Wei Zhang et al.
NEOPLASIA (2013)
Mechanisms of Glioma-Associated Neovascularization
Matthew E. Hardee et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates
Guido Wollmann et al.
CANCER JOURNAL (2012)
Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
Ryuichi Kanai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma
Wei Zhang et al.
MOLECULAR THERAPY (2012)
Replication-competent Herpes Simplex Virus Retargeted to HER2 as Therapy for High-grade Glioma
Eleonora Gambini et al.
MOLECULAR THERAPY (2012)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
Anti-angiogenic gene therapy in the treatment of malignant gliomas
NaTosha N. Gatson et al.
NEUROSCIENCE LETTERS (2012)
Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
Johanna K. Kaufmann et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Factors influencing helper-independent adeno-associated virus replication
Armel Nicolas et al.
VIROLOGY (2012)
RETROVIRAL REPLICATING VECTORS IN CANCER
Christopher R. Logg et al.
METHODS IN ENZYMOLOGY, VOL 507: GENE TRANSFER VECTORS FOR CLINICAL APPLICATION (2012)
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L. C. Hygino da Cruz et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
Ryuichi Kanai et al.
CLINICAL CANCER RESEARCH (2011)
Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Jennifer Lohr et al.
CLINICAL CANCER RESEARCH (2011)
Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
Atique U. Ahmed et al.
MOLECULAR THERAPY (2011)
MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
Mathias F. Leber et al.
MOLECULAR THERAPY (2011)
The biology of brain metastases-translation to new therapies
April F. Eichler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Targeting the Tumor Microenvironment in Cancer: why Hyaluronidase Deserves a second Look
Clifford J. Whatcott et al.
CANCER DISCOVERY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Impact of tumor microenvironment on oncolytic viral therapy
Jeffrey Wojton et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
Jayson Hardcastle et al.
MOLECULAR THERAPY (2010)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
Agda K. Lucio-Eterovic et al.
CLINICAL CANCER RESEARCH (2009)
Structure of Natural Killer Cell Receptor KLRG1 Bound to E-Cadherin Reveals Basis for MHC-Independent Missing Self Recognition
Yili Li et al.
IMMUNITY (2009)
Molecular Mechanisms of IFN-gamma to Up-Regulate MHC Class I Antigen Processing and Presentation
Fang Zhou
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
Rebecca J. Webster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus
Yoon-A Kang et al.
MOLECULAR THERAPY (2008)
Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies
Andreas Wortmann et al.
MOLECULAR THERAPY (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16
M. Aghi et al.
ONCOGENE (2008)
Impact of radiation therapy on the oncolytic adenovirus dl520:: Implications on the treatment of glioblastoma
Alexa Bieler et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy
Kazuhiko Kurozumi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Angiogenesis in brain tumours
Rakesh K. Jain et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
A. C. Shah et al.
GENE THERAPY (2007)
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells
Matteo Di Piazza et al.
JOURNAL OF VIROLOGY (2007)
Oncolytic viruses driven by tumor-specific promoters
Jayson Hardcastle et al.
CURRENT CANCER DRUG TARGETS (2007)
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
Cory Allen et al.
CANCER RESEARCH (2006)
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus
Hideaki Ito et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Oncolytic adenoviruses as antiglioma agents
Hong Jiang et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses
JJ Mezhir et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing
MHY Calle et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Poliovirus receptor CD155-targeted oncolysis of glioma
MK Merrill et al.
NEURO-ONCOLOGY (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Reovirus as an oncolytic agent against experimental human malignant gliomas
ME Wilcox et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
The cellular receptor for measles virus - Elusive no more
Y Yanagi
REVIEWS IN MEDICAL VIROLOGY (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
